Synthesis of pyranopyrazolo N-glycoside and pyrazolopyranopyrimidine C-glycoside derivatives as promising antitumor and antimicrobial agents
References
- 1. E. De Clercq, Antiviral drugs in current clinical use,.(2004) 115–133; DOI: 10.1016/j.jcv.2004.02.009.
- 2. P. J. O’Dwyer, S. A. King, J. Plowman, C. K. Grieshaber, D. F. Hoth and B. Leyland-Jones, Pyrazole: preclinical reassessment,(1988) 305–310.
- 3. A. Bekhit and T. Abdel-Aziem, Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents,.(2004) 1935–1945; DOI: 10.1016/j.bmc.2004.01.037.
- 4. K. L. Kees, J. J. Fitzgerald, K. E. Steiner, J. F. Mattes, B. Mihan and T. Tosi, New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones,.(1996) 3920–3928.
- 5. A. Geronikaki, E. Babaev, J. Dearden, W. Dehaen, D. Filimonov, I. Galaeva, V. Krajneva, A. Lagunin, F. macaev, G. Molodavkin, V. Poroikov, S. Pogrebnoi, V. Saloutin, A. Stepanchikova, E. Stingaci, N. Tkach, L. Vlad and T. Voroninaf, Design, synthesis, computational and biological evaluation of new anxyiolytics,(2004) 6559–6568; DOI: 10.1016/j.bmc.2004.09.016.
- 6. D. Sil, R. Kumar, A. Sharon, P. R. Malik and V. Ram, Stereoselective alkenylation of a 1,3-disubstituted pyrazol-5-one through ring transformation of 2H-pyran-2-ones,(2005) 3807–3809; DOI: 10.1016/j.tetlet.2005.03.207.
- 7. J. S. Larsen, M. A. Zahran, E. B. Pedersen and C. Nielsen, Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1,.(1999) 1167–1173.
- 8. A. Arrieta, J. R. Carrillo, F. P. Cossl, E. Ortiz, M. J. Gomez-Escalonilla, A. de la Hoz, F. Langa and A. Moreno, Efficient tautomerization hydrazone-azomethine imine under microwave irradiation. Synthesis of [4,3′] and [5,3′]bipyrazoles,(1998) 13167–13180; DOI: 10.1016/S0040-4020(98)00798-4.
- 9. G. M. Nitulescu, C. Draghici and O. T. Olaru, New potential antitumor pyrazole derivatives: Synthesis and cytotoxic evaluation,(2013) 21805–21818; DOI: 10.3390/ijms141121805.
- 10. J. L. Wang, D. Liu, Z. J. Zhang, S. Shan, X. Han, S. M. Srinivasula, C. M. Croce, E. S. Alnemri and Z. Huang, Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells,(2000) 7124–7129.
- 11. E. S. El-Tamany, F. A. El-Shahed and B. H. Mohamed, Synthesis and biological activity of some pyrazole derivatives,(1999) 9–18.
- 12. M. E. A. Zaki, H. S. Soliman, O. A. Hiekal and A. E. Rashad, Pyrazolopyranopyrimidines as a class of anti-inflammatory agents,..(2006) 1–5.
- 13. F. M. Abdelrazek, P. Metz, N. H. Metwally and S. F. El-Mahrouky, Synthesis and molluscicidal activity of new cinnoline and pyrano[2,3-]pyrazole derivatives,.(2006) 456–460.
- 14. F. M. Abdelrazek, P. Metz, O. Kataeva, A. Jager and S. F. EI-Mahrouky, Synthesis and molluscicidal activity of new chromene and pyrano[2,3-]pyrazole derivatives,(2007) 543–548.
- 15. N. Foloppe, L. M. Fisher, R. Howes, A. Potter, A. G. S. Robertson and A. E. Surgenor. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening,(2006) 4792–4802; DOI: 10.1016/j.bmc.2006.03.021.
- 16. S. A. El-Assiery, G. H. Sayed and A. Fouda, Synthesis of some new annulated pyrazolo-pyrido (or pyrano) pyrimidine, pyrazolopyridine and pyranopyrazole derivatives,(2004) 143–150.
- 17. C. M. Ashraf, S. S. Ali and A. Hussain, Organic reaction in aqueous solution, Part-VIII: Effect of Sonication on the reaction of thiosemicarbazide with ethyl acetoacetate,(1998) 145–149.
- 18. M. M. H. Bhuiyan, M. I. Hossain, M. A. Alam and M. M. Mahmud, Microwave assisted Knoevenagel condensation: synthesis and antimicrobial activites of some arylidene-malononitriles,(2012) 31–37.
- 19. S. R. Jain and A. Kar, The antibacterial activity of some essential oils and their combinations.(1971) 118–123; DOI: 10.1055/s-0028-1099675.
- 20. H. Ericsson and J. C. Sherris, Antibiotic sensitivity testing. Report of an international collaborative study,(1971) 1–90.
- 21. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer drug screening,.(1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.
- 22. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and J. M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines,.(1991) 757–776; DOI: 10.1093/jnci/83.11.757.
- 23. A. B. A. El-Gazzar, H. N. Hafez and G. A. M. Nawwar, New acyclic nucleoside analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines,(2009) 1427–1436; DOI: 10.1016/j.-ejmech.2008.09.030.
Language: English
Page range: 215 - 233
Accepted on: Feb 17, 2015
Published on: Sep 30, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2015 Hend N. Hafez, Abdel-Rhman B. A. El-Gazzar, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.